Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity.
Ríha M, Vopršalová M, Pilařová V, Semecký V, Holečková M, Vávrová J, Palicka V, Filipský T, Hrdina R, Nováková L, Mladěnka P.
Ríha M, et al. Among authors: pilarova v.
Naunyn Schmiedebergs Arch Pharmacol. 2014 Sep;387(9):823-35. doi: 10.1007/s00210-014-0995-z. Epub 2014 Jun 5.
Naunyn Schmiedebergs Arch Pharmacol. 2014.
PMID: 24899384